CS
Catherine Schulte Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
Past Year
0.72%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
88.9%
Neutral
11.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $28 |
54%
upside
| 2 | -4% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $82 |
37%
upside
| 2 | -26% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Outperform
Initiated
| $59 |
13%
upside
| 1 | -2.7% |
0
%
| 17 Feb ‘26 3 months ago |
|
|
|
Outperform
Initiated
| $120 |
8%
downside
| 1 | -17% |
0
%
| 17 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $165 |
26%
upside
| 3 | +3.8% |
0
%
| 25 Nov ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $88 |
16%
downside
| 2 | +48% |
0
%
| 4 Nov ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $17 |
75%
upside
| 4 | -5.9% |
0
%
| 24 Oct ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $1,230 |
7%
upside
| 3 | – |
–
| 4 Aug ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $567 |
20%
upside
| 3 | +3.1% |
0
%
| 24 Jul ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $229 |
26%
upside
| 4 | +0.14% |
0
%
| 23 Jul ‘25 10 months ago |
|